Skip to content

Imaging abdominal fatmass and its components with spectroscopy

Imaging abdominal fatmass and its components with spectroscopy - AFFECT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36650
Enrollment
25
Registered
2011-03-08
Start date
2011-05-04
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysfunctie van abdominaal vetweefsel dysfunctional abdominal fat dysfunctional visceral adipose tissue

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Between ages of 18 and 65 years. 2. Healthy volunteers 3. Male or female

Exclusion criteria

Exclusion criteria: 1. Known cardiovascular disease 2. Known renal, liver or pulmonary disease 3. Use of medication (except for oral anticonceptives, PPI*s, inhalation medication or topical unguents) 4. Pregnancy or lactation 5. Severe claustrophobia 6. Waist circumference too large to fit MRI. (> 200cm) 7. Metallic devices in the body

Design outcomes

Primary

MeasureTime frame
1. Unit defining the outcome of the MR-spectroscopic measurements. Again, because MR-spectroscopy has not been performed on abdominal adipose tissue before, no predefined unit is available. With the spectroscopy measurements of abdominal adipose tissue, we want to be able to distinguish different lipid components at their known place in the spectrum. These peaks should include: - the water peak at 4.65 ppm - the triglyceride peak at 0.9 and 1.3 ppm - the total unsaturated fatty acids peak at 5.4 ppm - the poly unsaturated fatty acids peak at 2.8 ppm These peaks should be easily determinable and should not overlap each other , making calculation of AUC*s possible. If these conditions are met, data will be regarded as adequate. If other peaks are present in the spectra of the abdominal adipose tissue, these will be analyzed in the same manner. With calculated AUC*s of each of these components ratio*s of the lipid components relative to water can be calculated. These ratio*s in abdominal adipose tissue can be compared to the same ratio*s obtained from spectroscopic measurements in other tissues, for example subcutaneous adipose tissue or hepatic tissue. When related to other tissue*s a comparison can be made regarding the amount of the different lipidcomponents. For this study, because we do not know what will be the most appropriate tissue to compare the spectroscopic measurements of abdominal adipose tissue to, we want to perform spectroscopy of liver, subcutaneous adipose tissue, skeletal muscle and spleen. Because we want to determine whether the ratio's differ when a person has a small or large amount of abdominal adipose tissue, half of the participantis will have a waistcircumference of >88cm (women) or >102cm (men). 2. Reproducibility of spectroscopic measurements Both interscan (i.e. intra-individual) and interobserver reproducibility will be defined using Bland-Altman plots and interclass correlation coefficients.

Secondary

MeasureTime frame
1. To compare spectroscopic measurements of participants with and without (laboratory) measurements of metabolic syndrome. 2. To compare adipokine profiles of participants with spectroscopic measurements (only when technique seems feasible).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)